Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase

L. Musilová, K. Kuča, Y.S. Jung, D. Jun

. 2009 ; 47 (6) : 545-550.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc11019588

INTRODUCTION: Organophosphorus pesticides and nerve agents are highly toxic to humans and other living organisms, primarily because of their interaction with enzyme acetylcholinesterase. The aim of our study was to find suitable reactivators of acetylcholinesterase and butyrylcholinesterase and to recommend the most efficacious compounds for the next evaluation as antidotes for intoxication by pesticides. METHODS: Eighteen structurally different oxime reactivators were tested for their in vitro ability to reactivate paraoxon-inhibited human erythrocyte acetylcholinesterase and human plasma butyrylcholinesterase to find out structure-activity relationship within this set of compounds. Their reactivation ability was compared with commercially available acetylcholinesterase reactivators (pralidoxime, methoxime, trimedoxime, obidoxime, and HI-6). RESULTS AND DISCUSSION: The best reactivation ability was achieved with obidoxime, trimedoxime, compounds K027, K075, K203, and K048. We have also tested reactivation of butyrylcholinesterase with the aim to recommend an efficient reactivator, able to perform a "pseudo catalytic" bioscavenger with butyrylcholinesterase, which is developed as new antidote of organophosphate poisonings. Such combination could allow an enhancement of prophylactic and therapeutic efficiency of administered enzyme. Compounds K117, K269, K075, and trimedoxime were found to be the most potent reactivators of inhibited butyrylcholinesterase. CONCLUSIONS: In this work, we have evaluated only reactivation of paraoxon-inhibited cholinesterases. To get better understanding of this problem, a larger number of organophosphorus inhibitors should be used.

Citace poskytuje Crossref.org

000      
03571naa 2200397 a 4500
001      
bmc11019588
003      
CZ-PrNML
005      
20121115115321.0
008      
110714s2009 xxk e eng||
009      
AR
024    __
$a 10.1080/15563650903058914 $2 doi
035    __
$a (PubMed)19586353
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Musilová, Lucie. $7 _AN039969
245    10
$a In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase / $c L. Musilová, K. Kuča, Y.S. Jung, D. Jun
314    __
$a Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic. lucie.musil@centrum.cz
520    9_
$a INTRODUCTION: Organophosphorus pesticides and nerve agents are highly toxic to humans and other living organisms, primarily because of their interaction with enzyme acetylcholinesterase. The aim of our study was to find suitable reactivators of acetylcholinesterase and butyrylcholinesterase and to recommend the most efficacious compounds for the next evaluation as antidotes for intoxication by pesticides. METHODS: Eighteen structurally different oxime reactivators were tested for their in vitro ability to reactivate paraoxon-inhibited human erythrocyte acetylcholinesterase and human plasma butyrylcholinesterase to find out structure-activity relationship within this set of compounds. Their reactivation ability was compared with commercially available acetylcholinesterase reactivators (pralidoxime, methoxime, trimedoxime, obidoxime, and HI-6). RESULTS AND DISCUSSION: The best reactivation ability was achieved with obidoxime, trimedoxime, compounds K027, K075, K203, and K048. We have also tested reactivation of butyrylcholinesterase with the aim to recommend an efficient reactivator, able to perform a "pseudo catalytic" bioscavenger with butyrylcholinesterase, which is developed as new antidote of organophosphate poisonings. Such combination could allow an enhancement of prophylactic and therapeutic efficiency of administered enzyme. Compounds K117, K269, K075, and trimedoxime were found to be the most potent reactivators of inhibited butyrylcholinesterase. CONCLUSIONS: In this work, we have evaluated only reactivation of paraoxon-inhibited cholinesterases. To get better understanding of this problem, a larger number of organophosphorus inhibitors should be used.
590    __
$a bohemika - dle Pubmed
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a antidota $x farmakologie $x chemie $7 D000931
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cholinesterasové inhibitory $x toxicita $7 D002800
650    _2
$a reaktivátory cholinesterasy $x farmakologie $x chemie $7 D002801
650    _2
$a erytrocyty $x enzymologie $x účinky léků $7 D004912
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a paraoxon $x toxicita $7 D010261
650    _2
$a kvantitativní vztahy mezi strukturou a aktivitou $7 D021281
700    1_
$a Kuča, Kamil, $d 1978- $7 xx0041831
700    1_
$a Jung, Young-Sik
700    1_
$a Jun, Daniel, $d 1976- $7 xx0040498
773    0_
$t Clinical Toxicology: The Official Journal of the American Academy of Clinical Toxicology & European Association of Poisons Centres & Clinical Toxicologists $w MED00013938 $g Roč. 47, č. 6 (2009), s. 545-550
910    __
$a ABA008 $b x $y 2
990    __
$a 20110715114325 $b ABA008
991    __
$a 20121115115337 $b ABA008
999    __
$a ok $b bmc $g 864466 $s 729466
BAS    __
$a 3
BMC    __
$a 2009 $x MED00013938 $b 47 $c 6 $d 545-550 $m Clinical toxicology $n Clin Toxicol (Phila)
LZP    __
$a 2011-3B09/Bjvme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé